Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme

This study reports the initial experience at the University of California San Francisco (UCSF) with tumor resection and permanent, low-activity iodine 125 ((125)I) brachytherapy in patients with progressive or recurrent glioblastoma multiforme (GM) and compares these results to those of similar pati...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Larson, David A., Suplica, Jeffrey M., Chang, Susan M., Lamborn, Kathleen R., McDermott, Michael W., Sneed, Penny K., Prados, Michael D., Wara, William M., Nicholas, M. Kelly, Berger, Mitchel S.
Médium: Artigo
Jazyk:Inglês
Vydáno: Duke University Press 2004
Témata:
Clinical Investigations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1871978/
https://ncbi.nlm.nih.gov/pubmed/15134626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/S1152851703000425
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky